Back to search results

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Castration-resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Samuel Denmeade, MD) · denmesa@jhmi.edu · 410-733-3232
Study leads

  • Samuel Denmeade, MD

    Principal Investigator

    Johns Hopkins University

View source on ClinicalTrials.gov(opens in a new tab)